Letters by company
Entegris INC
10 letters discussing ENTG. Everything written about it on this site is on its ticker page.
- The London Company Market Observations & Portfolio Commentary Large Cap – 3Q2026 vs. Russell 1000 Value The London Company attributes relative weakness to Russell 1000 Value reconstitution changes and renewed mega-cap technology exposure, while maintaining its bottom-up process. It added to NewMarket and argues that balance-sheet strength, durable dividends, conservative leverage and reasonable valuations offer ballast amid concentrated AI-led market leadership. 3Q2026 BLK $176BCVX $448BENTG $23B
- The London Company Market Observations & Portfolio Commentary Mid Cap – 3Q2026 vs. Russell Midcap The Mid Cap portfolio faced headwinds from underweights in energy and beaten-down software, alongside pressure at consumer-facing and building-products holdings. The strategy added Verisk, Honeywell Aerospace, TE Connectivity and CBRE, while exiting Bruker, Copart and Pool. The manager argues that quality businesses with conservative leverage and durable cash generation should benefit as higher rates pressure weaker balance sheets. 3Q2026 APPF $7.8BAVTR $12BCBRE $36B
- The London Company Market Observations & Portfolio Commentary: SMID Cap – 3Q2026 vs. Russell 2500 The London Company credited stock selection and its lower-volatility, quality-focused portfolio for resilience as rising rates and widening low-grade credit spreads punished speculative smaller stocks. It exited UniFirst and Lamb Weston, built Primo Brands into a full position, and added Somnigroup on expectations of operational improvement, merger synergies and an eventual mattress-market recovery. 3Q2026 CCC $4.5BDECK $11BENTG $23B
- The London Company Market Observations & Portfolio Commentary Large Cap – 3Q2026 vs. Russell 1000 The London Company added to NewMarket, citing AMPAC capacity expansion and management’s record of capital returns. It maintained conviction in Chevron, BlackRock, Entegris, Old Dominion Freight Line and Martin Marietta, while arguing that quality balance sheets, durable dividends and reasonable valuations provide ballast amid concentrated AI-driven market leadership. 3Q2026 BLK $176BCVX $448BENTG $23B
- The London Company Large Cap – 2Q2026 vs. Russell 1000 Value Market Update The Large Cap portfolio retained its quality bias as AI-led semiconductor and cyclical leadership left Quality and Yield factors behind. It trimmed Alphabet to maintain position limits, added to Republic Services for its defensive waste-services model, and argues that elevated AI spending, index concentration and valuations warrant discipline. 2Q2026 ENTG $23BGOOGL $3.9TMLM $37B
- Artisan Partners Artisan Mid Cap Fund Quarterly Commentary Artisan Mid Cap Fund added to Lattice Semiconductor, Comfort Systems, Guardant Health, Teledyne and Tradeweb while initiating Entegris, Modine Manufacturing and C.H. Robinson Worldwide. The fund exited ROBLOX, Insulet and Cencora, arguing that AI infrastructure, health care innovation and selected profit-cycle recoveries offer better opportunities than maturing or competitively challenged franchises. Q2 2026 0HQW COR $66BENTG $23B
- Artisan Partners Artisan Global Discovery Fund Quarterly Commentary Artisan Global Discovery Fund trimmed Twist Bioscience and Insmed, added to Lattice Semiconductor and Babcock, and exited ROBLOX, Colliers International and MongoDB as valuations, execution risks and competitive conditions changed. The portfolio initiated Entegris, Cellebrite and C.H. Robinson, while retaining emphasis on AI infrastructure, health care innovation and identifiable profit cycles. Q2 2026 0HQW ALAB $50BAS $17B
- Artisan Partners Artisan Global Discovery Fund Quarterly Commentary Artisan Global Discovery Fund reduced AI-infrastructure exposure by exiting Modine Manufacturing and Monolithic Power Systems, while concentrating capital in Lattice Semiconductor, Entegris and SiTime. The portfolio initiated Manhattan Associates, Okta and Clean Harbors, added to Twilio, West Pharmaceutical and RBC Bearings, and favored company-specific profit cycles amid higher rates, commodity costs and AI spending uncertainty. Q3 2026 CGNX $9.6BCLH $17BCOMP $7.5B
- Fenimore Asset Management Q2 2026 Quarterly Investment Commentary Fenimore added Ryan Specialty, Thermo Fisher Scientific, and Tyler Technologies while trimming or exiting selected holdings to fund higher-conviction opportunities. The firm argues that AI infrastructure demand favored semiconductor-linked businesses, while volatility in software, outsourcing, and defensive stocks created entry points for companies with durable competitive positions. Q2 2026 BOC $381MBR $21BEXLS $6.2B
- Fenimore Asset Management Quarterly Investment Commentary Fenimore maintained its quality bias as energy and speculative shares led markets, adding to discounted holdings while refusing to chase the rally. The strategies bought Gildan, Arthur J. Gallagher, Ryan Specialty and S&P Global, sold EOG Resources, and argued that AI fears created selective opportunities in software, brokers and information services. Q1 2026 ADI $189BAJG $66BBR $21B
